发现和两个不同的状态依赖的BamA抑制剂的结构基础
Dawei Sun1, Kelly M Storek2, Dimitry Tegunov1
1Department of Structural Biology, Genentech Inc., South San Francisco, CA, USA.
Nature communications
|October 8, 2024
概括
研究人员发现了杀死大肠杆菌的类宏循环,通过向Bama的极端状态来杀死大肠杆菌,Bama是格拉姆阴性细菌外膜组合中的关键蛋白质. 这些分子为抗生素发现提供了新的途径,目标是关键的细菌机械.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 基本的β-桶组装机 (BAM) 复合体,其核心为BAMA,对于将β-桶蛋白插入和折叠到Gram负细菌外膜至关重要.
- 尽管了解了Bama的结构和功能,但治疗用途的强效和选择性调节器很少.
研究的目的:
- 发现新的类宏循环,以向和调节Bama活动.
- 通过准Bama. coli的不同构造状态来识别杀死大肠杆菌的分子.
主要方法:
- 使用了体外选择方法与各种BAMA/BAM蛋白配方相结合.
- 对表现出对大肠杆菌具有抗菌活性的化物宏循环进行选.
主要成果:
- 鉴定向AMA-1 (PTB1),它结合了细胞外部位,将Bamma锁定在一个封闭的侧门形状中.
- 发现了 PTB2,它准了一个光结合点,将 BamA 困在一个开放的侧门形状中.
- 证明这些可以通过向Bama的极端构造状态来杀死大肠杆菌.
结论:
- PTB1和PTB2代表了研究BAMA功能的强大和有选择性的工具分子.
- 这些发现为开发针对Bama的新抗生素提供了基础.
- 发现的类宏循环可以作为调节其他动态整体膜蛋白的模板.
更多相关视频
相关概念视频
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Enzyme Inhibition
78.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


